U.S. Software Stock News

1-800-FLOWERS.COM (FLWS) has just posted Q3 2026 results with revenue of US$293.0 million and a basic EPS loss of US$1.56, while net income excluding extra items was a loss of US$100.1 million. The company has seen quarterly revenue move between US$331.5 million and US$775.5 million since Q3 2025, with EPS ranging from a loss of US$2.80 to a profit of US$1.11 over that period. Trailing twelve month EPS now sits at a loss of US$2.11 on revenue of about US$1.5 billion and a net loss of US$134.4...

Chimera Investment (CIM) opened 2026 with Q1 total revenue of US$47.0 million and basic EPS of a US$0.78 loss, setting a cautious tone around the latest financial update. Over the past year, quarterly revenue has moved between US$38.2 million and US$201.0 million, while basic EPS has ranged from a US$2.06 loss to US$1.79, giving you a wide band of outcomes to weigh as you consider how sustainable current margins are. See our full analysis for Chimera Investment. With the headline numbers on...

OraSure Technologies (OSUR) opened 2026 with Q1 revenue of US$27.9 million and a basic EPS loss of US$0.32, alongside a trailing twelve month revenue base of US$113.0 million and a basic EPS loss of US$1.04. Over recent quarters the company has seen revenue move from US$29.9 million in Q1 2025 and US$37.4 million in Q4 2024 to the latest US$27.9 million print. Quarterly basic EPS losses shifted from US$0.21 and US$0.14 in those periods to US$0.32, so investors are likely to focus on how...

Brighthouse Financial (BHF) opened 2026 with Q1 revenue of US$1.5b and a basic EPS loss of US$13.72, alongside net income excluding extra items of a US$792m loss. On a trailing 12 month basis, revenue stood at US$6.1b with a basic EPS loss of US$2.92 and a US$167m net loss. Over recent quarters the company has seen revenue move from US$2.4b in Q1 2025 to US$1.9b in Q4 2025 and US$1.5b in Q1 2026. Basic EPS has ranged from a loss of US$5.05 in Q1 2025 to a profit of US$10.80 in Q4 2024 before...

Radian Group (RDN) opened 2026 with Q1 revenue of US$466.3 million and basic EPS of US$0.94, setting the tone for how its earnings story is evolving against a trailing twelve month backdrop of US$1.37 billion in revenue and EPS of US$4.34. Over recent quarters, the company has seen revenue move between US$292.7 million and US$318.1 million, while quarterly EPS has ranged from US$0.99 to US$1.16, giving investors a clear look at how the latest print fits into its recent track record. With...

ATN International (ATNI) opened 2026 with Q1 revenue of US$182.2 million and a basic EPS loss of US$0.18, while trailing 12 month revenue stood at US$730.9 million against a net loss of US$14.9 million. Over recent quarters, revenue has moved in a tight band between US$179.3 million and US$184.2 million. During the same period, basic EPS has swung from a profit of US$0.18 in Q3 2025 to losses of US$0.56 in Q2 2025 and US$0.32 in Q4 2025. This sets up a quarter where investors are focused less...

M&T Bank is actively assessing targeted acquisitions within its 13 state footprint to increase regional scale. The company is focusing on adding density in existing markets rather than pursuing a national expansion strategy. This comes as regulators appear more open to bank mergers, creating a more supportive backdrop for deals. M&T Bank (NYSE:MTB) is sharpening its focus on regional growth, with management exploring acquisitions that fit within its existing footprint instead of chasing...

MBX Biosciences, Inc. recently reported first-quarter 2026 results, posting a US$23.58 million net loss and basic and diluted loss per share of US$0.51, both improving slightly from the same period in 2025. Alongside the earnings report, director Steven L. Hoerter received a mix of restricted stock units and stock options, underlining the company’s use of equity-based incentives tied to ongoing service. We’ll now examine how MBX Biosciences’ narrower quarterly loss and equity awards for its...

FY 2026 earnings snapshot and how the stories stack up NVE (NVEC) has just wrapped up FY 2026 with fourth quarter revenue of US$7.7 million and basic EPS of US$1.02, set against trailing twelve month revenue of US$26.3 million and EPS of US$3.14 as the stock trades at US$88.59. Over recent quarters the company has seen revenue range from US$6.1 million to US$7.7 million and quarterly EPS move between US$0.68 and US$1.02. This gives investors a clearer read on how the topline and per share...

Mirum Pharmaceuticals (MIRM) just posted Q1 2026 results with revenue of US$159.9 million, a basic EPS loss of US$13.43 and net income loss excluding extra items of US$790.2 million. The company has reported quarterly revenue of US$99.4 million in Q4 2024, US$111.6 million in Q1 2025, US$127.8 million in Q2 2025, US$133.0 million in Q3 2025 and US$148.9 million in Q4 2025, while EPS over those periods ranged between a loss of US$0.50 and a profit of US$0.06. For investors, a key focus this...

In recent months, Marvell Technology has reshaped its AI infrastructure profile through Nvidia’s US$2 billion investment and partnership, reported co-development talks with Alphabet on new AI chips, and the acquisitions of Celestial AI and Polariton Technologies to deepen its optical interconnect capabilities. Together, these moves signal Marvell’s push to become a core supplier of custom silicon and high-speed networking for hyperscale AI data centers that increasingly depend on specialized...

Hagerty (HGTY) opened 2026 with Q1 revenue of US$311.8 million and a basic EPS loss of US$0.06, as net income swung to a loss of US$6.5 million. The company has seen quarterly revenue shift from US$319.6 million and EPS of US$0.07 in Q1 2025 to US$311.8 million and an EPS loss of US$0.06 in Q1 2026, against a trailing twelve month EPS of US$0.26. This sets up a mixed start to the year, with margins firmly in focus for investors parsing this update. See our full analysis for Hagerty. With the...

Baron Health Care Fund recently highlighted Roivant Sciences (NasdaqGS:ROIV) for positive Phase 2 results of brepocitinib in cutaneous sarcoidosis. The fund called brepocitinib's data a potential major catalyst and suggested the market may be underestimating the drug's franchise value. This public endorsement draws fresh attention to Roivant's pipeline beyond earlier discussions about its valuation or analyst coverage. Roivant Sciences focuses on developing and commercializing therapies...

Camtek (CAMT) stock was in focus after the company reported record revenues and operating income, tied to high performance computing and advanced packaging for AI related applications, and outlined its expectations for growth into 2026. See our latest analysis for Camtek. The stock has been volatile around the results, with a 1-day share price decline of 4.67%, but a 30-day share price return of 21.27% and a 1-year total shareholder return approaching 3x. This points to strong momentum that...

Recent analyst actions around Home Depot (HD), including renewed coverage highlighting its Pro contractor focus and recent earnings that topped muted expectations, have pulled the stock back into the spotlight despite ongoing housing and spending headwinds. See our latest analysis for Home Depot. At a recent share price of US$322.64, Home Depot has seen pressure with a 90 day share price return of 16.23% and a year to date share price return of a 6.70% decline. The 3 year total shareholder...

Why Freshpet’s latest earnings matter for investors Freshpet (FRPT) just posted first quarter results showing sales of US$297.64 million and net income of US$48.51 million, compared with a net loss a year earlier. This has drawn fresh attention to the stock. See our latest analysis for Freshpet. Freshpet’s latest results and brand campaign land against a weaker price backdrop, with a 30 day share price return of 11.37% and a 1 year total shareholder return decline of 31.9%, suggesting longer...

Garrett Motion (GTX) recently reported Q1 2026 results alongside a higher full year outlook, combining stronger quarterly figures, new industrial contracts and progress in zero emission technologies to shape how investors are reassessing the stock. See our latest analysis for Garrett Motion. The recent Q1 release and raised full year guidance have coincided with a strong shift in sentiment, with a 49.34% 1 month share price return and a very large 5 year total shareholder return, suggesting...

Middleby (MIDD) opened 2026 with Q1 revenue of US$839.9 million and basic EPS of US$1.81, backed by trailing 12 month revenue of US$3.3 billion and EPS of US$7.34 that frame the latest quarter in a broader earnings context. Over the past few periods the company has seen quarterly revenue move from US$906.6 million in Q1 2025 to US$866.4 million in Q4 2025 and US$839.9 million in Q1 2026, while quarterly basic EPS shifted from US$1.72 to US$1.73 and then to US$1.81 across the same stretch...

Curious whether Chipotle Mexican Grill at around US$33.27 is a bargain or still priced for perfection? This breakdown will help you put the current stock price into context. Over the last week the stock posted a 2.1% decline, and over the past year it has returned a 35.3% decline, which may have some investors questioning whether sentiment has shifted or if there is a potential opening. Recent coverage has focused on Chipotle's position as a major US fast-casual restaurant chain and how its...

MDU Resources Group (MDU) opened 2026 with Q1 revenue of $606 million and basic EPS of $0.39, while trailing 12 month revenue stood at about $1.8 billion and EPS at $0.93. This sets a clear baseline for how the business is currently earning its way. The company has seen quarterly revenue shift from $674.8 million in Q1 2025 to $606 million in Q1 2026, with basic EPS moving from $0.40 to $0.39 over the same period. This gives investors a straightforward read on how recent trading compares with...

Covista (CVSA) shares reacted to a strong Q1 2026 earnings report, with revenue and adjusted EPS ahead of market expectations and full year guidance raised. This put the education provider’s recent execution in sharper focus for investors. See our latest analysis for Covista. The latest Q1 beat and guidance lift come after a steady build in momentum, with an 11.98% 90 day share price return and a 3 year total shareholder return of 183.77%, while the 1 year total shareholder return of 0.97%...

CF Industries Holdings (NYSE:CF) is dealing with ongoing operational disruptions at its Yazoo City, Mississippi Complex, expected to continue into late Q4 2026. The affected facility is a key manufacturing site for the company, with implications for near term nitrogen output and unit costs. At the same time, CF Industries is working on low carbon fertilizer collaborations with PepsiCo and ExxonMobil. These projects focus on lower emissions nitrogen products and long term offtake, during a...

In early May 2026, BigBear.ai Holdings, Inc. reported first-quarter 2026 results showing relatively flat revenue at US$34.44 million, a smaller net loss of US$56.76 million, sharply higher gross margins, and a 14% sequential backlog increase driven by a classified US$53 million intelligence community contract. The company also reaffirmed its full-year 2026 revenue guidance of US$135 million to US$165 million and highlighted growing contributions from higher-margin generative AI platforms...

S&P Global (SPGI) is moving ahead with a planned separation of its Mobility division by filing a Form 10 with the SEC for Mobility Global Inc. This step can reshape the stock’s risk and business mix. See our latest analysis for S&P Global. The latest Form 10 filing and Mobility separation plan come after a period where momentum has cooled, with a 1-day share price return of 1.21% at US$428.68 but a year to date share price return of negative 16.38%. The 3 year total shareholder return of...